Records containing: Short Gut Syndrome

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2025-11-25
  Successful Fiber Food Introduction in Short Bowel Syndrome
• CLINICAL_TRIALS study record update · 2025-10-01
  Functional Sucrase Deficiency in Short Bowel Syndrome Patients With Intestinal Failure
• CLINICAL_TRIALS study record update · 2025-08-17
  Clinical Tolerance and Microbiome Changes Following Fiber Food Introduction in Short Bowel Syndrome
• CLINICAL_TRIALS study record update · 2025-06-12
  A Phase 2, Placebo-Controlled, Randomized, Double-Blind Study of 2 Doses of Crofelemer for the Treatment of Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
• CLINICAL_TRIALS study record update · 2024-07-05
  Innovative Central Line Securement Device: Line Complications and Quality of Life in the Pediatric Population as Compared to Traditional Securement Device
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2015-02-18
  A Phase 3, Open Label Responder Treatment Period With a Randomized, Blinded, Three-Period Crossover, Followed by an Open Label Safety Period to Evaluate the Clinical Efficacy, Safety, and Pharmacokinetics of Investigational Drug MP-101 (Opium Tincture and Opium Tincture With Reduced Uncharacterized Material) to Treat Chronic Diarrhea in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-Diarrheals
• CLINICAL_TRIALS study record update · 2015-02-18
  A Phase 3, Open Label Extension Study for Subjects That Complete Study MP-101-CL-001